Effect of variants in COMT and UGT1A genes on clinical response in patients with Parkinson’s disease treated with opicapone

Ongentys (opicapone) - Ono Pharma, Neurocrine, BIAL

https://www.mdsabstracts.org/abstract/effect-of-variants-in-comt-and-ugt1a-genes-on-clinical-response-in-patients-with-parkinsons-disease-treated-with-opicapone/

E. Ojeda-Lepe; S. García-Díaz; R. Díaz Belloso; L. Muñoz-Delgado; S. Jesús; MT. Periñán; B. Benítez Zamora; AD. Adarmes-Gómez; D. Macías-García; M. Martín-Bornez; M. Bonilla-Toribio; D. Buiza-Rueda; R. Pineda-Sánchez; F. Carrillo; P. Gómez-Garre; P. Mir

Aug 31, 2023